Existing IRAK therapies lack effective selective IRAK4 inhibitors; tricyclic compounds target the kinase across autoimmune, inflammatory, and lymphoid conditions.
Exposed metal surfaces can distort LC separations; AMPcP and caffeine controls assess inertness and mechanical performance in one test.
Specific Formula 1 substituents provide organic-layer materials that support high OLED efficiency, stability, and low driving voltage.
A polycyclic dopant paired with a deuterated anthracene host narrows blue emission to FWHM ≤20 nm for efficient, long-lasting OLEDs.
A nitrogen-containing heterocyclic compound tunes energy levels for efficient 370–450 nm blue emission and longer OLED lifespan.